True Link Financial Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-636
Closed -$76.5K 281
2026
Q1
$76.5K Buy
+636
New +$73.4K ﹤0.01% 175
2024
Q3
Sell
-1,830
Closed -$227K 71
2024
Q2
$227K Buy
+1,830
New +$236K 0.02% 59
2023
Q4
Sell
-3,352
Closed -$345K 93
2023
Q3
$345K Buy
3,352
+302
+10% +$32.5K 0.04% 85
2023
Q2
$352K Hold
3,050
0.04% 91
2023
Q1
$324K Hold
3,050
0.04% 98
2022
Q4
$338K Hold
3,050
0.05% 92
2022
Q3
$263K Buy
+3,050
New +$272K 0.04% 118
2022
Q1
Sell
-1,150
Closed -$88K 221
2021
Q4
$88K Sell
1,150
-182
-14% -$14.5K 0.01% 406
2021
Q3
$100K Sell
1,332
-200
-13% -$15.2K 0.01% 383
2021
Q2
$119K Buy
1,532
+117
+8% +$8.7K 0.02% 278
2021
Q1
$104K Buy
1,415
+210
+17% +$15.5K 0.02% 381
2020
Q4
$94K Buy
+1,205
New +$92.2K 0.01% 444

Other funds holding MRK

True Link Financial Advisors's MRK Position: Q2 2026 in Review

True Link Financial Advisors sold out of Merck (MRK) in Q2 2026, closing a stake of 636 shares — an estimated $76.5K sold.

True Link Financial Advisors first reported a position in MRK in Q4 2020 and held it in 12 quarters. The position peaked at $352K in Q2 2023. 3,818 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • True Link Financial Advisors reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • True Link Financial Advisors sold 636 Merck shares in Q2 2026, an estimated $76.5K.
  • True Link Financial Advisors first reported a position in Merck in Q4 2020 and held it in 12 quarters.
  • True Link Financial Advisors's Merck position peaked at $352K in Q2 2023.
  • 3,818 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on True Link Financial Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.